288 related articles for article (PubMed ID: 32378666)
1. [Required Human and System Resources for Genomic Medicine].
Aimono E; Nishihara H
Yakugaku Zasshi; 2020; 140(5):651-655. PubMed ID: 32378666
[TBL] [Abstract][Full Text] [Related]
2. [Training Medical Staff with Basic Skills for Data Science in Genomic Medicine].
Tomida S; Morita M; Yamashita N; Hirasawa A; Toyooka S
Yakugaku Zasshi; 2020; 140(5):657-661. PubMed ID: 32378667
[TBL] [Abstract][Full Text] [Related]
3. [Learning from My Experience: Outpatient Care for Cancer Multigene Genomic Testing].
Aimono E; Iguchi A; Mochida K; Imai M; Hayashi H; Nishihara H
Yakugaku Zasshi; 2020; 140(5):667-668. PubMed ID: 32378669
[TBL] [Abstract][Full Text] [Related]
4. [Roles of Pharmacists in Cancer Genomic Medicine].
Terada T
Yakugaku Zasshi; 2020; 140(5):663-666. PubMed ID: 32378668
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
7. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
[TBL] [Abstract][Full Text] [Related]
8. Toward clinical genomics in everyday medicine: perspectives and recommendations.
Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
[TBL] [Abstract][Full Text] [Related]
9. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
Wilson BJ; Miller FA; Rousseau F
J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
[TBL] [Abstract][Full Text] [Related]
10. The emerging clinical relevance of genomics in cancer medicine.
Berger MF; Mardis ER
Nat Rev Clin Oncol; 2018 Jun; 15(6):353-365. PubMed ID: 29599476
[TBL] [Abstract][Full Text] [Related]
11. The NCI-MATCH trial and precision medicine in gynecologic cancers.
Barroilhet L; Matulonis U
Gynecol Oncol; 2018 Mar; 148(3):585-590. PubMed ID: 29366510
[TBL] [Abstract][Full Text] [Related]
12. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract][Full Text] [Related]
13. An Overview of DNA Analytical Methods.
Arboleda VA; Xian RR
Methods Mol Biol; 2019; 1897():385-402. PubMed ID: 30539459
[TBL] [Abstract][Full Text] [Related]
14. Cancer genomics and inherited risk.
Stadler ZK; Schrader KA; Vijai J; Robson ME; Offit K
J Clin Oncol; 2014 Mar; 32(7):687-98. PubMed ID: 24449244
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing-based gene panel tests for the management of solid tumors.
Nagahashi M; Shimada Y; Ichikawa H; Kameyama H; Takabe K; Okuda S; Wakai T
Cancer Sci; 2019 Jan; 110(1):6-15. PubMed ID: 30338623
[TBL] [Abstract][Full Text] [Related]
16. Physician interpretation of genomic test results and treatment selection.
Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
[TBL] [Abstract][Full Text] [Related]
17. Genomic testing for pancreatic cancer in clinical practice as real-world evidence.
Hayashi H; Tanishima S; Fujii K; Mori R; Okamura Y; Yanagita E; Matsuoka R; Amano T; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Pancreatology; 2018 Sep; 18(6):647-654. PubMed ID: 30055942
[TBL] [Abstract][Full Text] [Related]
18. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
19. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
20. Integration of genomics in cancer care.
Santos EM; Edwards QT; Floria-Santos M; Rogatto SR; Achatz MI; MacDonald DJ
J Nurs Scholarsh; 2013 Mar; 45(1):43-51. PubMed ID: 23294839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
